109 related articles for article (PubMed ID: 12942241)
1. Evaluation of tumour markers in molar pregnancy.
Hegab HM; Schindler AE; Rizk M; Ramadan M
Arch Gynecol Obstet; 2003 Aug; 268(3):151-4. PubMed ID: 12942241
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.
Ercan Ş; Kaymaz Ö; Yücel N; Orçun A
Arch Gynecol Obstet; 2012 Mar; 285(3):579-84. PubMed ID: 21792548
[TBL] [Abstract][Full Text] [Related]
3. The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEA.
Tayyar M; Tutus A
Int J Fertil Womens Med; 1999; 44(5):256-9. PubMed ID: 10569455
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of tumor markers in gestational trophoblastic diseases.
Ahmad AE; Dehaghani AS; Shaker M; Fattahi MJ
J Reprod Med; 2008 Dec; 53(12):930-4. PubMed ID: 19160651
[TBL] [Abstract][Full Text] [Related]
5. Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
Thomakos N; Rodolakis A; Zagouri F; Zacharakis D; Sotiropoulou M; Akrivos N; Haidopoulos D; Papadimitriou CA; Dimopoulos MA; Antsaklis A
Arch Gynecol Obstet; 2013 Jan; 287(1):97-102. PubMed ID: 22941327
[TBL] [Abstract][Full Text] [Related]
6. Measurement of tumor markers in chronic hemodialysis patients.
Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
[TBL] [Abstract][Full Text] [Related]
7. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
9. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
11. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
12. [CA-125 serum level in early pregnancy follow hMG/hCG stimulated and unstimulated cycles].
Wilke G; Hinney B; Rath W; Henze C; Wuttke W; Kuhn W
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):941-6. PubMed ID: 2128287
[TBL] [Abstract][Full Text] [Related]
13. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
[TBL] [Abstract][Full Text] [Related]
14. Preevacuation serum CA 125 in complete hydatidiform mole.
Tangtrakul S; Srisupandit S; Chailurkit LO; Rajatanavin R
Gynecol Oncol; 1997 Mar; 64(3):487-9. PubMed ID: 9062156
[TBL] [Abstract][Full Text] [Related]
15. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
16. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
[TBL] [Abstract][Full Text] [Related]
17. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
[TBL] [Abstract][Full Text] [Related]
19. Ovarian molar pregnancy.
Church E; Hanna L; New F; Uku A; Awad H; Watson AJ
J Obstet Gynaecol; 2008 Aug; 28(6):660-1. PubMed ID: 19003680
[No Abstract] [Full Text] [Related]
20. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
Tangtakul S; Srisupundit S
J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
